What is Subtractive SELEX? It is a specialized version of SELEX used to generate aptamers (single-stranded DNA or RNA oligonucleotides) that bind with high affinity and specificity to a target of interest (e.g., a protein, cell, small molecule) while actively excluding binding to closely related non-targets (e.g., a non-pathogenic vs. pathogenic strain, a healthy vs. cancerous cell, or a target in a complex mixture). The "subtractive" step removes sequences that bind to unwanted counter-targets, ensuring the final aptamer pool is highly specific. Core Workflow of a Subtractive SELEX Service A typical service follows these key stages: 1. Project Design & Library Synthesis Client Consultation: Defining the target of interest (e.g., recombinant protein, whole cell) and the critical counter-target(s) for subtraction (e.g., isotype control protein, non-target cell line). Library Design: A service provider synthesizes a vast random-sequence oligonucleotide library (typically 10^14 - 10^15 unique sequences) flanked by constant primer regions. 2. The Subtractive SELEX Cycle (Repeated 8-15 Rounds) This is the iterative heart of the service: * a. Negative Selection (Subtraction): The oligonucleotide pool is incubated with the counter-target (or complex background, like serum). Sequences that bind to this unwanted material are discarded. * b. Positive Selection: The unbound sequences from (a) are then incubated with the target of interest. The bound sequences are recovered. * c. Washing: Non-specific or weakly bound sequences are washed away.…
What is SELEX? First, a quick recap: SELEX (Systematic Evolution of Ligands by EXponential enrichment) is the gold-standard process for discovering aptamers (single-stranded DNA or RNA molecules that bind to a specific target with high affinity and specificity). It involves iterative cycles of binding, partitioning, and amplification. "Free Solution SELEX" Explained Free Solution SELEX (also known as non-immobilized SELEX) is a specific technical approach. Its key characteristic is that neither the target molecule nor the library is fixed to a solid support (like beads, a column, or a chip) during the binding step. How it works: Binding: The random oligonucleotide library is mixed with the free, soluble target in solution. Partitioning: The key challenge is separating the bound sequences from the unbound ones without using immobilization. Common methods include: Nitrocellulose Filter Binding: Aptamer-target complexes are trapped on a filter, while free sequences pass through. Gel Filtration/Size Exclusion: Separates complexes (larger) from unbound sequences (smaller). Capture Techniques: Using a brief, weak tag on the target (like biotin) to pull down complexes after binding in solution. Amplification: The bound sequences are eluted, amplified by PCR (for DNA) or RT-PCR (for RNA), and purified for the next round. Advantages of Free Solution SELEX: Native Target Conformation: The target is in its natural, free state. There's no risk of…
What is CE-SELEX? SELEX (Systematic Evolution of Ligands by EXponential Enrichment) is the standard process for aptamer development. It involves iterative rounds of selection and amplification to enrich nucleic acid sequences that bind tightly to a target molecule. Traditional SELEX often uses immobilization of the target on beads or filters, which can be slow (8-15 rounds) and may introduce bias by selecting for sequences that bind to the immobilization matrix itself. CE-SELEX uses Capillary Electrophoresis as the separation mechanism. The key principle is that when an aptamer binds to its target, it forms a complex with a different charge-to-size ratio, causing it to migrate at a different time (shifted peak) in the capillary compared to the unbound nucleic acid library. This complex can be isolated and collected with exquisite precision. Core Advantages of a CE-SELEX Screening Service A service provider offering CE-SELEX delivers significant benefits: Extreme Speed and Efficiency: Often requires only 2-4 rounds of selection to obtain high-affinity aptamers (nanomolar to picomolar Kd), compared to many more rounds in traditional SELEX. This translates to weeks or months of time saved. Solution-Phase Selection: The target is free in solution, eliminating immobilization bias. This allows for selection against targets in their native conformation and enables selection for small molecules and…
Core Principle Nitrocellulose membrane filter binding exploits a simple but powerful property: nitrocellulose avidly binds proteins and protein-nucleic acid complexes, but does not efficiently bind free, single-stranded DNA or RNA. By passing a mixture of the target protein and a random oligonucleotide library through the membrane, sequences that bind to the protein are retained (as a complex), while unbound sequences are washed away. Typical Workflow of a Service Provider A professional service will manage this complex, iterative process for you: 1. Project Design & Library Synthesis Consultation: Defining your target (purified protein is essential), desired aptamer properties (affinity, specificity, buffer conditions), and format (DNA or RNA). Library Design: A synthetic library of up to 10^15 random sequences (e.g., 40-60 nt random core, flanked by constant primer regions) is prepared. 2. The SELEX Cycles (Iterative Screening) Incubation: The target protein is incubated with the nucleic acid library under optimized conditions (buffer, temperature, time). Positive Selection (Binding & Capture): The mixture is passed through a nitrocellulose membrane. Protein-aptamer complexes stick to the membrane. Washing: Mild washing removes weakly bound or non-specific sequences. Elution: Bound sequences are recovered by denaturing the protein (e.g., using heat, phenol-chloroform, or high-concentration urea). Amplification: For DNA SELEX: The eluted DNA is directly amplified by PCR. For…
What is Magnetic Bead SELEX? SELEX (Systematic Evolution of Ligands by EXponential Enrichment) is the gold-standard process for discovering aptamers—single-stranded DNA or RNA molecules that bind to a specific target with high affinity and specificity, similar to antibodies. Magnetic Bead SELEX is a widely used variant where the target molecule is immobilized on magnetic beads. This format offers significant advantages in automation, handling, and efficiency. Why Choose a Magnetic Bead SELEX Service? Developing aptamers in-house is time-consuming, requires specialized expertise, and involves significant optimization. A professional service provides: Expertise & Experience: Knowledge of library design, PCR optimization, and counter-selection strategies. Specialized Equipment: Access to automated magnetic separation systems, NGS, and bioinformatics. Time & Cost Efficiency: Faster turnaround (typically 2-4 months) than setting up a new lab. Higher Success Rate: Proven protocols to avoid common pitfalls like PCR bias or selection of non-specific binders. Typical Workflow of a Magnetic Bead SELEX Service Phase 1: Project Design & Target Preparation Consultation: You define the target (e.g., a protein, small molecule, cell), desired affinity (Kd), and application (diagnostics, therapeutics, sensors). Target Immobilization: The service provider chemically conjugates your target to the surface of magnetic beads (e.g., streptavidin-biotin, NHS-amine coupling). A "negative selection" bead (without target) is also prepared to remove…
What is Whole-tissue Section SELEX? It's an advanced Systematic Evolution of Ligands by EXponential enrichment (SELEX) technique where the selection target is not a purified protein or single cell type, but an intact, pathological tissue section (e.g., a slice of a human tumor biopsy on a glass slide). The core idea is to select DNA or RNA aptamers that bind specifically to the molecular landscape of diseased tissue, while simultaneously negating binding to adjacent healthy tissue from the same patient. The Standard SELEX vs. Whole-Tissue Section SELEX Feature Standard SELEX Whole-Tissue Section SELEX Target Purified protein, single cell type, or simple mixture. Complex, native tissue architecture with millions of molecular targets in their natural context. Goal Find an aptamer for a known, pre-defined target. Discover aptamers for unknown, disease-specific biomarkers without prior target identification. Context Target is isolated, may have altered conformation. Targets are in their native state, with intact post-translational modifications, protein complexes, and tissue microenvironments. Counter-Selection Against a buffer or a simple non-target (e.g., BSA). Against a serial section of adjacent healthy tissue from the same patient, ensuring disease specificity. Why Is This a Powerful Service? Target-Agnostic Discovery: You don't need to know the biomarker in advance. The process "lets the tissue decide" what the best molecular targets are.…
What is Whole-cell SELEX? Whole-cell SELEX (Systematic Evolution of Ligands by EXponential enrichment) is a technique used to discover aptamers (single-stranded DNA or RNA molecules) that bind specifically to a target living cell. Unlike traditional SELEX that uses a purified protein target, whole-cell SELEX presents the target in its native, complex cellular environment. This allows for the selection of aptamers against: Native cell-surface proteins in their proper folding and post-translational modifications. Complex targets like transmembrane receptors in their natural lipid environment. Unknown surface biomarkers without prior knowledge of the cell's molecular makeup. Specific cell states (e.g., activated, cancerous, infected) based on differences in surface expression. The Core Process: How Whole-cell SELEX Works A professional service will manage this complex, iterative pipeline: Library & Design: Starting with a vast, random synthetic oligonucleotide library (10^14 - 10^15 unique sequences). Positive Selection: Incubating the library with the target cells (e.g., cancer cells, stem cells, bacteria). Aptamers that bind to any surface structure are retained. Counter-Selection (Critical Step): The bound pool is then exposed to non-target or control cells (e.g., healthy cells, a different cell line). Sequences that bind to these are discarded. This step is crucial for generating specificity. Elution & Amplification: Aptamers specifically bound to the target cells are recovered, amplified by PCR…
What is Small Molecule SELEX? SELEX is an iterative in vitro selection process that sifts through a vast random library of nucleic acid sequences (typically 10^13 - 10^15 different molecules) to find the few that bind tightly and specifically to a target. The Challenge with Small Molecules: Low epitope density: Small molecules offer limited surface area for binding, making it hard to find high-affinity aptamers. Immobilization required: They must be attached to a solid support (beads, chip, column) for partitioning, which can mask potential binding sites or introduce non-specific interactions. Negative Selection is Crucial: To avoid selecting aptamers that bind to the immobilization matrix instead of the target. Standard Service Workflow (What the Provider Does): Project Design & Target Immobilization: Consultation: The provider works with you to understand the target's chemistry, desired affinity, and application (e.g., biosensor, therapeutic inhibitor, diagnostic). Conjugation: They chemically conjugate your small molecule to an appropriate carrier (e.g., beads, magnetic particles, agarose resin, or a surface like a chip). This is a critical, proprietary step for many providers. The SELEX Cycle (Repeated 8-15 rounds): Incubation: The vast oligonucleotide library is incubated with the immobilized target. Partitioning: Unbound sequences are washed away. Sequences bound to the target (and unfortunately, sometimes to the matrix) are retained. Elution: Bound…
What is Protein SELEX? SELEX (Systematic Evolution of Ligands by EXponential Enrichment) is an iterative, in vitro process used to discover aptamers—single-stranded DNA or RNA molecules that bind to a specific target (like a protein) with high affinity and specificity. Protein SELEX specifically refers to using a purified protein as the target to isolate aptamers against it. These aptamers are often called "chemical antibodies" due to their similar binding function. Core Workflow of a Protein SELEX Service A professional service will manage this entire complex process, typically involving the following stages: 1. Project Design & Consultation Target Characterization: Discussing the target protein's properties (size, purity, stability, domains, post-translational modifications). Selection Strategy: Choosing the right SELEX variant (e.g., Nitrocellulose filter, Magnetic bead, Capillary Electrophoresis, or Cell-SELEX for membrane proteins). Defining counter-selection steps to avoid binders to unwanted tags or impurities. Library Design: Using a standard or custom random oligonucleotide library (e.g., 40-60 random nucleotides flanked by primer sites). 2. The SELEX Cycle (Repeated 8-15 Rounds) mermaid graph TD A[Start: ssDNA/RNA Library<br>~10^15 unique sequences] --> B{Incubation with<br>Target Protein}; B --> C[Partition: Separate<br>Bound from Unbound Sequences]; C --> D[Elution: Recover<br>Bound Sequences]; D --> E[Amplification:<br>PCR (DNA) or RT-PCR (RNA)]; E --> F[Purification:<br>Regenerate ssDNA/RNA for next round]; F --> G{Enrichment<br>Sufficient?}; G -- No…
What is an Aptamer? First, a quick reminder: Aptamers are short, single-stranded DNA or RNA oligonucleotides that bind to a specific target with high affinity and specificity. They are often called "chemical antibodies." The Core Service: SELEX (The Screening Process) The service revolves around executing a SELEX (Systematic Evolution of Ligands by EXponential enrichment) campaign. This is an iterative, in-vitro combinatorial chemistry process that screens a vast random library (10^14 - 10^15 unique sequences) to find the few that bind your target. A standard SELEX workflow includes: Library Design & Synthesis: Creating the initial random oligonucleotide pool. Incubation: The library is exposed to the target. Partitioning: Bound sequences are separated from unbound ones (the most critical step, varying by target type). Amplification: The bound sequences are amplified (usually by PCR for DNA, RT-PCR for RNA). Counter-Selection (Negative Selection): To increase specificity, the pool is exposed to non-target surfaces (e.g., immobilization matrix, related proteins) to remove non-specific binders. Repetition: Steps 2-5 are repeated for 8-15 rounds until a high-affinity pool is enriched. Cloning & Sequencing: The final pool is cloned, and individual aptamer sequences are identified via Next-Generation Sequencing (NGS). Bioinformatics & Analysis: NGS data is analyzed to identify candidate sequences, often clustered into families based on sequence/structure motifs. Characterization: Top candidates…
